Brian B. Hoffman

8.5k total citations · 2 hit papers
167 papers, 6.8k citations indexed

About

Brian B. Hoffman is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Brian B. Hoffman has authored 167 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 46 papers in Physiology and 35 papers in Cellular and Molecular Neuroscience. Recurrent topics in Brian B. Hoffman's work include Receptor Mechanisms and Signaling (57 papers), Neuropeptides and Animal Physiology (29 papers) and Adipose Tissue and Metabolism (19 papers). Brian B. Hoffman is often cited by papers focused on Receptor Mechanisms and Signaling (57 papers), Neuropeptides and Animal Physiology (29 papers) and Adipose Tissue and Metabolism (19 papers). Brian B. Hoffman collaborates with scholars based in United States, Japan and Australia. Brian B. Hoffman's co-authors include Robert J. Lefkowitz, Gerald M. Reaven, Helen Ho, Terrence F. Blaschke, In‐Sul Hwang, Arthur Swislocki, Mary K. Goldstein, Helen Chang, Richard Z. Lin and Thomas Michel and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Brian B. Hoffman

167 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fructose-induced insulin resistance and hypertension in rats.

1987 735 citations Brian B. Hoffman, Gerald M. Reaven et al. profile →
Alpha-adrenergic receptor subtypes: Quantitative assessment by ligand binding

1979 217 citations Brian B. Hoffman, Robert J. Lefkowitz et al. Life Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian B. Hoffman United States	45	2.7k	1.9k	1.6k	1.4k	1.4k	167	6.8k
John L. Reid United Kingdom	49	2.2k 0.8×	1.8k 0.9×	1.5k 0.9×	3.9k 2.8×	1.4k 1.0×	363	10.1k
Robert Ruffolo United States	48	3.1k 1.2×	1.2k 0.6×	504 0.3×	1.9k 1.3×	1.9k 1.4×	188	6.8k
Julie A. Johnson United States	60	4.5k 1.7×	1.2k 0.6×	2.2k 1.3×	2.7k 1.9×	1.1k 0.8×	346	14.1k
Bernard Waeber Switzerland	56	2.3k 0.9×	1.5k 0.8×	2.4k 1.4×	6.9k 4.9×	856 0.6×	439	11.1k
Haralambos Gavras United States	58	4.1k 1.6×	1.4k 0.7×	2.7k 1.7×	6.6k 4.6×	922 0.7×	352	12.8k
Addison A. Taylor United States	45	1.3k 0.5×	1.1k 0.6×	877 0.5×	2.3k 1.6×	253 0.2×	187	6.9k
Marc de Gasparo Switzerland	49	4.2k 1.6×	1.2k 0.6×	3.5k 2.1×	6.3k 4.4×	1.2k 0.9×	212	9.9k
Frans H. H. Leenen Canada	53	2.3k 0.9×	1.1k 0.6×	2.6k 1.6×	5.3k 3.7×	656 0.5×	298	8.9k
Irvine H. Page United States	56	1.9k 0.7×	1.3k 0.7×	1.5k 0.9×	2.9k 2.0×	1.0k 0.7×	336	10.3k
Emanuel Rubin United States	57	3.5k 1.3×	1.5k 0.8×	959 0.6×	875 0.6×	866 0.6×	228	10.9k

Countries citing papers authored by Brian B. Hoffman

Since Specialization

Citations

This map shows the geographic impact of Brian B. Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian B. Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian B. Hoffman more than expected).

Fields of papers citing papers by Brian B. Hoffman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian B. Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian B. Hoffman. The network helps show where Brian B. Hoffman may publish in the future.

Co-authorship network of co-authors of Brian B. Hoffman

This figure shows the co-authorship network connecting the top 25 collaborators of Brian B. Hoffman. A scholar is included among the top collaborators of Brian B. Hoffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian B. Hoffman. Brian B. Hoffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Payabvash, Seyedmehdi, John C. Benson, Jeffrey Rykken, et al.. (2016). Susceptible vessel sign: identification of arterial occlusion and clinical implications in acute ischaemic stroke. Clinical Radiology. 72(2). 116–122. 8 indexed citations

Yu, Qian‐sheng, Harold W. Holloway, J.L. Flippen-Anderson, et al.. (2001). Methyl Analogues of the Experimental Alzheimer Drug Phenserine: Synthesis and Structure/Activity Relationships for Acetyl- and Butyrylcholinesterase Inhibitory Action. Journal of Medicinal Chemistry. 44(24). 4062–4071. 71 indexed citations

Kerb, Reinhold, et al.. (2000). Analysis of Drug Pharmacology towards Predicting Drug Behavior by Expression Profiling Using High‐Density Oligonucleotide Arrays. Annals of the New York Academy of Sciences. 919(1). 9–15. 15 indexed citations

Tangphao, Oranee, Stephan Chalon, Heitor Moreno, Brian B. Hoffman, & Terrence F. Blaschke. (1999). Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia. Clinical Science. 96(2). 199–207. 20 indexed citations

Chin, Jin Han, et al.. (1996). Impaired cAMP-mediated gene expression and decreased cAMP response element binding protein in senescent cells. American Journal of Physiology-Cell Physiology. 271(1). C362–C371. 41 indexed citations

Hu, Zhiwei, Xin Shi, Masahiro Okazaki, & Brian B. Hoffman. (1995). Angiotensin II induces transcription and expression of alpha 1-adrenergic receptors in vascular smooth muscle cells. American Journal of Physiology-Heart and Circulatory Physiology. 268(3). H1006–H1014. 52 indexed citations

Sakaue, Motoyoshi, et al.. (1994). Enhanced transcription of the human α2A-adrenergic receptor gene by cAMP: Evidence for multiple cAMP responsive sequences in the promoter region of this gene. Cellular Signalling. 6(1). 73–82. 7 indexed citations

Bedarida, Gabriella, et al.. (1994). Histamine-induced venodilation in human beings involves both H1 and H2 receptor subtypes. Journal of Allergy and Clinical Immunology. 93(3). 606–614. 36 indexed citations

Ford, Gary A., et al.. (1993). Mechanism of Bradykinin-Induced Venodilation in Humans. Journal of Cardiovascular Pharmacology. 21(2). 241–248. 34 indexed citations

10.

Skinner, Michael, et al.. (1992). Atenolol Compared with Nifedipine: Effect on Cognitive Function and Mood in Elderly Hypertensive Patients. Annals of Internal Medicine. 116(8). 615–623. 41 indexed citations

11.

Costa, Elizabeth M., Brian B. Hoffman, & Gilda H. Loew. (1992). Opioid agonists binding and responses in SH-SY5Y cells. Life Sciences. 50(1). 73–81. 15 indexed citations

12.

Ford, Gary A., et al.. (1991). Responsiveness of peripheral veins to vasodilators and the effect of nifedipine on α-adrenergic responsiveness in hypertension. Clinical Pharmacology & Therapeutics. 50(2). 192–198. 4 indexed citations

13.

Sheu, Wayne Huey‐Herng, Arthur Swislocki, Brian B. Hoffman, Yian Chen, & Gerald M. Reaven. (1991). Comparison of the Effects of Atenolol and Nifedipine on Glucose, Insulin, and Lipid Metabolism in Patients With Hypertension. American Journal of Hypertension. 4(3 Pt 1). 199–205. 60 indexed citations

14.

Sheu, Wayne Huey‐Herng, Arthur Swislocki, Brian B. Hoffman, Gerald M. Reaven, & Y.-D. Ida Chen. (1990). Effect of Prazosin Treatment on HDL Kinetics in Patients With Hypertension. American Journal of Hypertension. 3(10_Pt_1). 761–768. 7 indexed citations

15.

Reaven, Gerald M. & Brian B. Hoffman. (1989). Hypertension as a disease of carbohydrate and lipoprotein metabolism. The American Journal of Medicine. 87(6). S2–S6. 77 indexed citations

16.

Eichler, Hans‐Georg, Irmgard Eichler, Norman J. Lewiston, Terrence F. Blaschke, & Brian B. Hoffman. (1989). Responsiveness of superficial hand veins to adrenergic stimuli in patients with cystic fibrosis. Clinical Science. 76(3). 283–287. 6 indexed citations

17.

Hoffman, Brian B., Hexi Chang, & G M Reaven. (1987). Stimulation and Inhibition of Lipolysis in Isolated Rat Adipocytes: Evidence for Age-Related Changes in Responses to Forskolin and PGE₁. Hormone and Metabolic Research. 19(8). 358–360. 4 indexed citations

18.

Tsujimoto, Gozoh, et al.. (1986). Age-related change in adrenergic regulation of glycogen phosphorylase in rat hepatocytes. Mechanisms of Ageing and Development. 33(2). 167–175. 6 indexed citations

19.

Spiss, Christian K., Christopher M. Smith, Gozoh Tsujimoto, Brian B. Hoffman, & Mervyn Maze. (1985). Prolonged hyporesponsiveness of vascular smooth muscle contraction after halothane anesthesia in rabbits.. PubMed. 64(1). 1–6. 13 indexed citations

20.

Stiles, Gary L., et al.. (1983). Guanine nucleotides and alpha1 adrenergic receptors in the heart. Biochemical Pharmacology. 32(1). 69–71. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact